Anvisa issues alert on indiscriminate use of drugs for erectile dysfunction

News Healthcare & Pharma Guidance

Date: 5th Sep, 2025 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

On May 9, 2024, the National Health Surveillance Agency (Anvisa) issued an alert regarding the risks associated with the indiscriminate use of drugs such as sildenafila, tadalafila, vardenafila, udenafila, and lodenafila. The agency warned about the potential severe effects of these substances when used recreationally or esthetically, including cardiovascular events, hypotension, vision or hearing loss, and psychological dependence.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Anvisa issues alert on indiscriminate use of drugs for erectile dysfunction

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Anvisa issues alert on indiscriminate use of drugs for erectile dysfunction

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.